Low Prevalence of Microsatellite Instability in Interval Gastric Cancers

Abstract

Esophagogastroduodenoscopy (EGD) is recommended at 2-year intervals in countries with a high prevalence of gastric cancer. The aim of this study was to determine whether interval gastric cancers that develop within 2years of a previous complete screening are associated with microsatellite instability (MSI). Newly diagnosed gastric cancer patients who had undergone gastrectomy were included. Of these 459 patients, 177 were classified as interval gastric cancer since they were diagnosed within 2years of a previous EGD. Noninterval gastric cancer patients were subclassified into 65 patients who underwent previous EGD between the past 2 and 10years and 217 patients without EGD during the last 10years. Analysis for MSI was conducted using two mononucleotide and three dinucleotide markers. MSI was found more frequently in noninterval gastric cancers than in interval gastric cancers (p=0.009). Interval gastric cancers were associated with a higher prevalence of early gastric cancer (p=0.006), smaller size (p<0.001), and lower TNM stages (p=0.006). On logistic regression analysis, noninterval gastric cancers were related to MSI (p=0.010) and larger size (≥4cm) (p=0.009). Subjects with interval gastric cancer showed better survival than those with noninterval gastric cancer (p=0.006). During a 2-year screening interval, noninterval gastric cancers tend to be larger, more advanced, and associated with MSI. Biannual EGD screening is effective for detecting small gastric cancers at an early stage, but is not useful in detecting gastric cancers with MSI.